2009
DOI: 10.1002/anie.200905200
|View full text |Cite
|
Sign up to set email alerts
|

Targeted Optimization of a Protein Nanomachine for Operation in Biohybrid Devices

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
18
0

Year Published

2011
2011
2019
2019

Publication Types

Select...
8

Relationship

3
5

Authors

Journals

citations
Cited by 19 publications
(18 citation statements)
references
References 37 publications
0
18
0
Order By: Relevance
“…The functionalization of biohybrid devices that exploit actomyosin-based cargo transport for molecular diagnostics and other nanotechnological applications (Amrute-Nayak et al, 2010; Lard et al, 2013; Persson et al, 2013) is another area that will certainly benefit from the use of EMD 57033 and the development of compounds that stabilize their target proteins against stress-induced denaturation, precipitation, and proteolytic degradation. The effective and simple long-term storage of chip-based nanobiosensors, where actomyosin-driven transport substitutes microfluidics and forms the basis for novel detection schemes, is a precondition for the commercial viability of such devices.…”
Section: Discussionmentioning
confidence: 99%
“…The functionalization of biohybrid devices that exploit actomyosin-based cargo transport for molecular diagnostics and other nanotechnological applications (Amrute-Nayak et al, 2010; Lard et al, 2013; Persson et al, 2013) is another area that will certainly benefit from the use of EMD 57033 and the development of compounds that stabilize their target proteins against stress-induced denaturation, precipitation, and proteolytic degradation. The effective and simple long-term storage of chip-based nanobiosensors, where actomyosin-driven transport substitutes microfluidics and forms the basis for novel detection schemes, is a precondition for the commercial viability of such devices.…”
Section: Discussionmentioning
confidence: 99%
“…In this context, investigators have regularly relied on Diatrack’s dedicated functionalities for in vitro motility studies (‘Particle production…’ ‘in vitro motility assay’). For example, Taft et al demonstrated that myosin-5b is a processive motor 55 and Amrute-Nayak et al succeeded in engineering single and double headed myosin-5 motors, whose mechanochemical properties (force, speed, processivity) could be systematically controlled by variations in ATP, ionic strength, and Mg 2+ -ion concentrations 56 . Further, the effects of small molecules on myosins can be easily assessed in the in vitro motility assay by characterizing the changes in the velocity of filaments.…”
Section: Survey Of Applicationsmentioning
confidence: 99%
“…For further development of point-of-care diagnostic devices, it will be important to perform in depth studies of the mechanisms that limit the capability of engineered cytoskeletal filament shuttles to transport various cargoes, from single macromolecules to cells. Other important developments would be new approaches for optimizing (Amrute-Nayak et al 2010) and stabilizing the protein components in order to increase their shelf-life and methods to ensure the compatibility of motor function with complex fluid environments or alternatively, bypassing this complication by innovative approaches. Additionally, it will be important to select appropriate applications for the different motor system to optimally utilize the high cargo-carrying capacity of microtubule kinesin and the high speed and increased capability of miniaturization associated with myosin II propelled actin filaments.…”
Section: Developments From 2005 and Onwardsmentioning
confidence: 99%